Edition:
United States

Celsion Corp (CLSN.OQ)

CLSN.OQ on NASDAQ Stock Exchange Capital Market

2.49USD
19 Oct 2018
Change (% chg)

$-0.15 (-5.68%)
Prev Close
$2.64
Open
$2.63
Day's High
$2.63
Day's Low
$2.46
Volume
32,954
Avg. Vol
35,206
52-wk High
$3.95
52-wk Low
$1.75

Chart for

About

Celsion Corporation is an oncology drug development company. The Company's product candidate is ThermoDox, a heat-activated liposomal encapsulation of doxorubicin, which is in Phase III clinical trial for treatment of primary liver cancer (the OPTIMA Study) and a Phase II clinical trial for treatment of recurrent chest wall... (more)

Overall

Beta: 1.31
Market Cap(Mil.): $47.03
Shares Outstanding(Mil.): 17.75
Dividend: --
Yield (%): --

Financials

  CLSN.OQ Industry Sector
P/E (TTM): -- 119.85 32.14
EPS (TTM): -1.73 -- --
ROI: -69.91 1.96 12.83
ROE: -178.78 1.12 14.95

Earnings vs. Estimates